Abstract

Introduction: in primary and secondary prevention (PP and SP)randomized controlled trials (RCTs) of implantable cardioverter-defibrillator (ICD) and cardiac resynchronization therapy (CRT-D)devices, the median age of enrolled patients (pts) was approximately 64 years(yrs). The purpose of this study is to describe: actual prescribing practice of ICD and CRT-D therapy in the elderly, given their under-representation in these studies. Methods: The ACT Registry is a prospective database that includes over 5,000 pts with an ICD or CRT-D implanted for standard indications. They are herein reported stratified by age ≥ 70 and ≥ 80 yrs old, indication (PP vs SP), device type, and then by device type for each indication. Results : Of 4,560 pts with age recorded, 41% (n= 1,867) of those undergoing initial implantation were ≥ 70 yrs, and 12% (n=546) were ≥ 80 yrs old. For those ≥ 70–79 yrs old (n=1,321), 82% had a PP indication. For those ≥ 80 yrs old (n=546), 79.5% had a PP indication. The distribution of’ CRT-D, dual chamber (DC) ICDs and single chamber (SC) ICDs was 33.1%, 40.7%, and 26.2% respectively for pts 70–79 yrs old. For pts ≥ 80 yrs old, a similar distribution was observed: 32.8%, 40.7% and 26.6%, respectively. For PP pts 70–79 yrs old (n=1,083), the distribution of CRT-D, DC, and SC devices was 37.5%, 37.2%, and 25.3%, respectively. For PP pts ≥ 80, yrs (n=434), the distribution of CRT-D, DC, and SC devices was 37.1%, 36.2%, and 26.7%, respectively. Among SP pts 70–79 (n=238), the distribution of CRT-D, DC and SC devices was 13%, 56.7%, and 30.3% respectively. Among SP pts ≥ 80 (n=112), the distribution of CRT-D, DC and SC devices was 16.1%, 58.0% and 25.9% respectively. For PP pts ≥ 80 yrs receiving a CRT-D, 36% had a QRS duration > 120 ms, 41% were NYHA Class III-IV, and 20.4% met both criteria. Conclusions: Although relatively few elderly pts were included in RCTs on which current practice is based, over 40% of new devices are implanted in pts ≥ 70, and over 10% in pts ≥ 80 yrs. Despite a PP ICD indication in 80% of elderly pts, only ~ 25% receive SC devices. Of elderly pts receiving a CRT-D, < 40% have a QRS duration or NYHA Class meeting usual accepted implant criteria. These data indicate that study of device efficacy and selection in the elderly in needed.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call